Panbela Therapeutics
(OTC) PBLA
Panbela Therapeutics Financials at a Glance
Market Cap
$1,000
Revenue (TTM)
$0.00
Net Income (TTM)
$27.91M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
41.55 (High)
Dividend
$0.00
Beta (Volatility)
41.55 (High)
Price
$0.00
Volume
51
Open
$0.00
Price
$0.00
Volume
51
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $2.50
Dividend
$0.00
Beta (Volatility)
41.55 (High)
Price
$0.00
Volume
51
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $2.50
PBLA News
PBLA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Panbela Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Jennifer K. Simpson, PhD
Website
www.panbela.comHeadquarters
Waconia, MN 55387, US
PBLA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
99%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.00K
Shares Outstanding
4.85M
Volume
51
Short Interest
0.00%
Avg. Volume
3.59K
Financials (TTM)
Gross Profit
$25.65M
Operating Income
$51.29M
EBITDA
$51.29M
Operating Cash Flow
$25.25M
Capital Expenditure
$0.00
Free Cash Flow
$25.25M
Cash & ST Invst.
$2.58M
Total Debt
$5.19M
Panbela Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$7.17M
+8.7%
Gross Margin
0.00%
N/A
Market Cap
$1.00K
N/A
Market Cap/Employee
$142.86
N/A
Employees
7
N/A
Net Income
$7.17M
+8.4%
EBITDA
$6.73M
+14.2%
Quarterly Fundamentals
Net Cash
$6.25M
-45.8%
Accounts Receivable
$332.00K
+114.2%
Inventory
$0.00
N/A
Long Term Debt
$3.19M
-23.8%
Short Term Debt
$3.20M
+220.0%
Return on Assets
-2.14%
N/A
Return on Invested Capital
99.41%
N/A
Free Cash Flow
$2.12M
+68.2%
Operating Cash Flow
$2.12M
+68.2%